: A randomized blind study found Ladasten superior to placebo in reducing main symptoms of exhaustion with high safety and no addictive potential. Summary of Effects and Safety
: This study on ResearchGate explains how the drug works by regulating tyrosine hydroxylase to boost dopamine levels in the brain.
: Research suggests it is well-tolerated with no "withdrawal syndrome" upon stopping. However, it is banned by the World Anti-Doping Agency (WADA) due to its performance-enhancing properties. Purchasing and Regulation ladasten buy
: In Russia, it is a prescription drug for asthenic disorders (chronic fatigue).
: Unlike caffeine or amphetamines, it provides a "calm lift" by simultaneously reinforcing the GABA system while raising dopamine. : A randomized blind study found Ladasten superior
: It is generally unscheduled but not FDA-approved, meaning it is often sold through gray-market suppliers as a "research chemical" or nootropic.
: It has been used as a performance enhancer in sports and is detectable in standard drug screenings. However, it is banned by the World Anti-Doping
Ladasten (chemically known as ) is an "actoprotector" that combines psychostimulant and anti-anxiety (anxiolytic) effects. Developed in Russia in the 1980s, it is primarily used to treat fatigue and neurasthenia without the "crash" or withdrawal symptoms typical of standard stimulants. Key Scientific Overviews